Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 6
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
HE4 as a Biomarker for Endometrial Cancer.
Behrouzi R, Barr CE, Crosbie EJ. Behrouzi R, et al. Among authors: barr ce. Cancers (Basel). 2021 Sep 23;13(19):4764. doi: 10.3390/cancers13194764. Cancers (Basel). 2021. PMID: 34638250 Free PMC article. Review.
DEveloping Tests for Endometrial Cancer deTection (DETECT): protocol for a diagnostic accuracy study of urine and vaginal samples for the detection of endometrial cancer by cytology in women with postmenopausal bleeding.
Jones ER, Carter S, O'Flynn H, Njoku K, Barr CE, Narine N, Shelton D, Rana D, Crosbie EJ. Jones ER, et al. Among authors: barr ce. BMJ Open. 2021 Jul 28;11(7):e050755. doi: 10.1136/bmjopen-2021-050755. BMJ Open. 2021. PMID: 34321307 Free PMC article.
Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer.
Behrouzi R, Ryan NAJ, Barr CE, Derbyshire AE, Wan YL, Maskell Z, Stocking K, Pemberton PW, Bolton J, McVey RJ, Crosbie EJ. Behrouzi R, et al. Among authors: barr ce. Cancers (Basel). 2020 Jan 23;12(2):276. doi: 10.3390/cancers12020276. Cancers (Basel). 2020. PMID: 31979212 Free PMC article.
15 results